23,916 Shares in Trupanion, Inc. (NASDAQ:TRUP) Bought by Edgestream Partners L.P.

Edgestream Partners L.P. bought a new position in shares of Trupanion, Inc. (NASDAQ:TRUP) in the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund bought 23,916 shares of the financial services provider’s stock, valued at approximately $1,153,000. Edgestream Partners L.P. owned approximately 0.06% of Trupanion at the end of the most recent reporting period.

A number of other institutional investors also recently bought and sold shares of the business. Inceptionr LLC purchased a new stake in Trupanion during the 4th quarter worth about $224,000. Raymond James Financial Inc. purchased a new stake in Trupanion during the 4th quarter worth about $593,000. Proficio Capital Partners LLC purchased a new stake in Trupanion during the 4th quarter worth about $976,000. Charles Schwab Investment Management Inc. lifted its holdings in Trupanion by 2.1% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 306,752 shares of the financial services provider’s stock worth $14,785,000 after buying an additional 6,338 shares during the last quarter. Finally, Steward Partners Investment Advisory LLC lifted its holdings in Trupanion by 12.4% during the 4th quarter. Steward Partners Investment Advisory LLC now owns 11,805 shares of the financial services provider’s stock worth $569,000 after buying an additional 1,300 shares during the last quarter.

Trupanion Stock Up 2.3 %

Trupanion stock opened at $33.20 on Wednesday. Trupanion, Inc. has a fifty-two week low of $19.69 and a fifty-two week high of $57.90. The company has a debt-to-equity ratio of 0.39, a quick ratio of 1.66 and a current ratio of 1.71. The company has a market capitalization of $1.41 billion, a P/E ratio of -144.35, a PEG ratio of 6.02 and a beta of 1.70. The stock has a 50-day simple moving average of $43.50 and a 200-day simple moving average of $47.33.

Trupanion (NASDAQ:TRUP) last posted its quarterly earnings data on Wednesday, February 19th. The financial services provider reported $0.04 EPS for the quarter, missing the consensus estimate of $0.06 by ($0.02). The company had revenue of $337.31 million for the quarter, compared to analysts’ expectations of $335.41 million. Trupanion had a negative net margin of 0.75% and a negative return on equity of 3.08%. Equities research analysts expect that Trupanion, Inc. will post 0.13 earnings per share for the current year.

Insider Buying and Selling at Trupanion

In other Trupanion news, CEO Margaret Tooth sold 2,294 shares of the company’s stock in a transaction that occurred on Tuesday, March 4th. The stock was sold at an average price of $31.39, for a total transaction of $72,008.66. Following the completion of the sale, the chief executive officer now directly owns 118,784 shares of the company’s stock, valued at $3,728,629.76. This represents a 1.89 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, SVP Emily Dreyer sold 14,025 shares of the company’s stock in a transaction that occurred on Friday, March 7th. The shares were sold at an average price of $32.41, for a total value of $454,550.25. Following the sale, the senior vice president now directly owns 27,645 shares of the company’s stock, valued at approximately $895,974.45. This represents a 33.66 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 25,984 shares of company stock valued at $850,362 in the last ninety days. Insiders own 5.50% of the company’s stock.

Analysts Set New Price Targets

A number of brokerages have issued reports on TRUP. Stifel Nicolaus decreased their price target on Trupanion from $44.00 to $41.00 and set a “hold” rating for the company in a report on Thursday, February 20th. Piper Sandler reduced their target price on Trupanion from $57.00 to $52.00 and set an “overweight” rating for the company in a report on Thursday, February 20th. Two research analysts have rated the stock with a hold rating, four have issued a buy rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat.com, Trupanion has an average rating of “Moderate Buy” and a consensus price target of $46.60.

Trupanion Company Profile

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.